与原相关的基因表达水平预测了预后和免疫治疗反应
Jianchao Wang1, Zhentian Liu2, Liyan Lin1
1Department of Pathology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.
概括
胃癌的预后因缺乏生物标志物而有所不同. 一个新的原评分 (CS) 可以预测患者的治疗结果和免疫治疗反应,帮助开发有针对性的治疗方法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 胃癌患者对治疗和预后的反应不同.
- 缺乏可靠的生物标志物阻碍了胃癌的个性化治疗选择.
研究的目的:
- 确定用于预测胃癌预后和治疗反应的新生物标志物.
- 评估与原相关的基因表达作为预测因素的实用性.
主要方法:
- 分析了来自103名胃癌患者的RNA测序数据.
- 用于集群分析的非负矩阵因子化.
- 原分数 (CS) 用ssGSEA计算,并在独立的队列 (TCGA,ACRG,免疫疗法) 中验证.
主要成果:
- 集群分析揭示了不同的瘤透状态.
- 与原相关的途径在集群之间被差异地激活.
- 在TCGA和ACRG队列中,CS独立预测了整体存活率 (p<0.05).
- 在免疫治疗中,更高的CS与更差的客观响应率 (ORR) 相相关 (p=0.0025).
- 高CS与抑制的细胞死亡途径和较差的瘤微环境有关.
结论:
- 原分数 (CS) 是胃癌的经过验证的独立预后因素.
- CS可能反映免疫疗法的有效性,并识别出患有较差瘤微环境的患者.
- CS为临床预后评估提供了一种新的方法,并指导开发原向疗法.
更多相关视频
相关概念视频
Fibril-associated Collagen
2.6K
Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
2.6K
Collagens are the Major Structural Proteins of ECM
4.3K
Three main types of fibers are secreted by fibroblasts: collagen fibers, elastic fibers, and reticular fibers. Collagen fiber is made from fibrous protein subunits linked together to form a long, straight fiber. Collagen fibers, while flexible, have great tensile strength, resist stretching, and give ligaments and tendons their characteristic resilience and strength. These fibers hold connective tissues together, even during the body's movement.
Connective tissue proper includes loose...
Connective tissue proper includes loose...
4.3K
Tumor Immunotherapy
557
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K


